-

Chinese Scientists and AntiCancer Inc. Discovery the Most Effective Weight-Loss Method

SAN DIEGO--(BUSINESS WIRE)--A collaborative study between scientists at the Shanghai University of Traditional Chinese Medicine and AntiCancer Inc. of San Diego has discovered in a clinical trial that a 5-day water–only fast resulted in large weight loss and reduction in body-mass index (BMI), decrease in metabolic-syndrome and inflammation biomarkers and a large increase in anti-aging factors. The weight loss and other benefits of the water-only fast remained for a long period of time after its completion.

The study was led by Professor Lijun Jia of the Shanghai University of Traditional Chinese Medicine in collaboration with AntiCancer Inc. of San Diego.

“This study demonstrates a safe method to lose a large amount of weight and gain many metabolic benefits in a very short period of time that is more effective than other methods of caloric restriction,” said Dr. Qinghong Han, Senior Scientist at AntiCancer Inc.

“The water-only 5-day-fast clinical trial is an important example of a highly effective collaboration between Chinese and AntiCancer scientists that can benefit people all over the world, especially the obesity pandemic,” said Dr. Robert M. Hoffman, Founder and CEO of AntiCancer Inc. This collaborative study of Chinese and AntiCancer scientists was just published in the current issue of Clinical and Translational Medicine.

AntiCancer Inc. uniquely also offers patient-derived orthotopic xenograft (PDOX) mouse models, which most closely resemble the cancer patient. AntiCancer also offers HDRA 3-dimensional tumor culture for cancer drug discovery and evaluation. Anticancer is also developing tumor-targeting bacteria; and methioninase which targets methionine addiction, a general hallmark of cancer, discovered by Dr. Hoffman in 1976. AntiCancer discovered and developed pluripotent hair follicle stem cells which form neurons and other cell types for regenerative medicine and has pioneered tumor-specific fluorescence-guided surgery.

AntiCancer Inc. is the oldest biotech firm in San Diego, founded in 1984 and has subsidiaries in Tokyo, Beijing, Seoul and Nanjing. Follow AntiCancer on anticancer.com.

Contacts

Qinghong Han, MD. all@anticancer.com

AntiCancer Inc.


Release Versions

Contacts

Qinghong Han, MD. all@anticancer.com

More News From AntiCancer Inc.

AntiCancer Inc. Has Received a New Patent That Revolutionizes Individualized Mouse Models of Human Cancer Patients by Increasing the Patient-tumor Establishment Rate in Mice to Close to 100%

SAN DIEGO--(BUSINESS WIRE)--AntiCancer Inc. announced it has just received US Patent 11,871,731 that describes a method to increase the rate of establishment of patient tumors in mice to close to 100%. Previously the establishment rates were much lower, in many cases only 10-20% in laboratories around the world. “The new method allows, for the first time, large scale and commercial success of establishing mouse models for each cancer patient to individualize and optimize their cancer therapy, a...

AntiCancer’s PDOX Mouse Model Has Demonstrated High Clinical Concordance Which Will Enable Precise Individualized Chemotherapy of Cancer Patients

SAN DIEGO--(BUSINESS WIRE)--AntiCancer Inc. of San Diego has announced its PDOX mouse model of human cancer patients has demonstrated high concordance of chemotherapy in the mouse and patient. “This new result means AntiCancer has made the first steps for precise, individualized cancer chemotherapy,” said Qinghong Han, Senior Scientist at AntiCancer Inc. “The PDOX mouse model has the patient’s tumor implanted in the same organ in the mouse as it was in the patient enabling very accurate predict...

AntiCancer Inc. Scientists Discover the Fundamental Basis of the Malignancy of Cancer

SAN DIEGO--(BUSINESS WIRE)--In a new article appearing in the current issue of the Cell Press scientific journal iScience, AntiCancer Inc. of San Diego has demonstrated that the addiction of cancer to the common amino acid methionine is the basis of the malignancy of cancer. The new article demonstrates that the excess methionine needed by cancer cells for their addiction is used to pathologically modify proteins that control gene expression (called histones), by a process called hyper-methylat...
Back to Newsroom